You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

April 24, 2015

Web Version  | Share with a colleague

Facebook Like Twitter Tweet

Today's Headlines

Teva's Mylan bid set to shake up industry

Teva Pharmaceutical's unsolicited $40 billion offer to acquire Mylan N.V. is expected to shake up the pharmaceutical industry, especially in the areas of generic and specialty drugs. » Specialty, generic drug shake up

Children with cerebral palsy, epilepsy need flu vaccine but don't always get it

Children who have neurological disorders, such as cerebral palsy or epilepsy, are no more likely to be vaccinated against influenza than children without these conditions, despite the increased risk for complications from flu these kids experience, according to a study. » What you need to do

Continuing Education

MTM essentials for asthma: Part 1

This month Drug Topics and the University of Connecticut School of Pharmacy offer a new CPE series: MTM for the patient with respiratory disease. Pharmacists can earn up to 18 hours of CPE credit with 9 monthly knowledge-based activities (released April – December 2015). This month the series kicks off with MTM essentials for asthma management, covering the pathophysiology of asthma, clinical presentations of asthma, assessment methods, and nonpharmacologic management options.

To read and print the article with TEST questions, click here

To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the session code 15DT29-YKX36.


Announcement: Our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

EDITOR'S PICK

Beware of fake Botox in the U.S.

A counterfeit version of onabotulinumtoxinA (Botox) was found in the United States and may have been sold to physicians' offices and medical clinics nationwide. This version is considered unsafe and should not be used. » See the fake Botox photos

 

RELATED ARTICLES

[BLOG]: Cost containment through the use of generic medications

Formulary managers can help improve vaccination rates

RESOURCES

Latest Clinical News

Powered by Modern Medicine Advanstar Medical Communications Group